Serum Institute of India (SII) on Saturday, 9 April, announced their decision to revise the price of their COVID-19 vaccine Covishield for private hospitals from Rs 600 to Rs 225 per dose.
Taking to Twitter to announce their decision, Serum Institute CEO Adar Poonawalla said:
"We are pleased to announce that after discussion with the Central Government, SII has decided to revise the price of COVISHIELD vaccine for private hospitals from Rs 600 to Rs 225 per dose."
This comes a day after the Centre opened vaccination for all adults for the 'precautionary' or the third dose.
Soon after SII's announcement, Bharat Biotech, which manufactures Covaxin, said that they will also slash pricing to Rs 225 from 1,200
Precaution dose for all those who are above 18 years of age will open on 10 April. This is not mandatory, and those who would like to receive their third dose must register on Co-WIN to book a slot for inoculation.
(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)